Affiliation: H. Lee Moffitt Cancer Center and Research Institute
- Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White
Mayo Clinic College of Medicine, Rochester, MN, USA
BMC Cancer 9:170. 2009..Inhibitors of kappaB (IkappaB) prevent NF-kappaB activation by sequestering NF-kappaB proteins in the cytoplasm until IkappaB proteins are phosphorylated and degraded...
- Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan
Department of Epidemiology and Genetics, Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
Cancer Epidemiol Biomarkers Prev 19:600-4. 2010..03). This study underscores the need for replication of putative findings in genetic association studies...
- Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers
Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
Cancer Epidemiol Biomarkers Prev 17:397-404. 2008..10 frequency; odds ratio, 0.07; P = 0.01) compared with the most common haplotype (0.39 frequency). These results suggest that genetic polymorphisms in the glycoslyation process may be novel risk factors for ovarian cancer...
- The Mitochondrial Genome and Ovarian Cancer RiskCatherine Phelan; Fiscal Year: 2010..Finally, this study will address a number of the questions on the role of mitochondria in cancer that were posed in the program announcement (PA-08-143). ..